LEXARIA BIOSCIENCE CORP. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share
LEXARIA BIOSCIENCE CORP. (LEXX) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share of $0.00 per share for the 3-month period ending 2022-02-28, per its 10-Q filed 2022-04-11.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare · last filed 2022-04-11
- LEXARIA BIOSCIENCE CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2022-02-28 was $0.00.
- LEXARIA BIOSCIENCE CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2021-11-30 was $0.00.
- LEXARIA BIOSCIENCE CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2021-02-28 was -$0.01.
- LEXARIA BIOSCIENCE CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2020-11-30 was $0.00.
- LEXARIA BIOSCIENCE CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2016 was $0.00.
- LEXARIA BIOSCIENCE CORP. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2015 was $0.00.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month |
|---|---|---|---|
| 2022-02-28 | $0.00 10-Q · filed 2022-04-11 | $0.00 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $0.00 10-Q · filed 2022-01-14 | ||
| 2021-02-28 | -$0.01 10-Q · filed 2022-04-11 | -$0.01 10-Q · filed 2022-04-11 | |
| 2020-11-30 | $0.00 10-Q · filed 2022-01-14 | ||
| 2016-08-31 | $0.00 10-K · filed 2016-11-29 | ||
| 2015-08-31 | $0.00 10-K · filed 2016-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |